Riyadh, March 03, 2024, Merck, a prominent company in the fields of science, technology, and medicine, has officially opened a new regional office in the Kingdom of Saudi Arabia. This marks Riyadh as the designated regional office for the Middle East and North Africa, solidifying its status as a key hub for investments in the Middle East.
Aligned with the objectives of Saudi Vision 2030, Merck aims to operate in accordance with the transformative vision by offering innovative solutions that cater to the evolving healthcare needs of both citizens and residents in the region.
The inauguration ceremony, attended by several Saudi officials, company representatives, and Merck Group Saudi Arabia Managing Director Yaser Alhagan, signifies a significant step in Merck's expansion strategy in the region. Alhagan highlighted the collaborative efforts between Merck Group and the Ministry of Investment, emphasizing the importance of Riyadh as a strategic location that supports the company's growth and aligns with the Kingdom's commitment to accelerating the development of companies and fostering a supportive environment for the private sector.
